LOUISVILLE, Ky.--(BUSINESS WIRE)--XLerateHealth (XLH), a nationally recognized healthcare accelerator headquartered in Louisville, KY, today announced the selection of seven startup companies to participate in the 2021 Louisville bootcamp. This year’s program will be fully virtual in light of the success of last year’s COVID-19 adaptations.
“We are pleased to welcome this year’s cohort and are especially excited to see over half the startups founded by clinicians working towards commercializing their innovations, and four of the seven companies founded and led by women,” said Jackie Willmot, CEO and co-founder of XLH.
Recent successes of XLerateHealth alumni companies include:
- eBlu Solutions (XLH 2016) raised an $11.4M Series A round led by OCA Ventures with co-investors Mutual Capital Partners and FCA Venture Partners’ Health Innovations II.
- Cellgorithmics (XLH 2019) recently raised $4.5M from a prominent Silicon Valley VC firm.
- RxLighting (XLH 2020) was selected to join "Microsoft for Startups", a global program dedicated to accelerating the trajectory of high-potential B2B startups to enable growth at scale. The company also recently closed a $3M Series Seed round (led by HealthX Ventures).
- IBIS Therapeutics (XLH 2020) recently entered into an agreement with Mayo Clinic that commits up to $500K investment in convertible debt by Mayo in a pre-seed round.
The 2021 XLH Louisville startup cohort kicks off its accelerator program on Wednesday, August 11, and will culminate with a virtual Demo Day pitch to investors, healthcare ecosystem partners, and the startup community on Thursday, October 28th.
XLerateHealth’s 2021 Louisville Cohort
20Lighter (Tampa, FL) is a unique program that targets visceral fat and dietary inflammation to support patients who are ineligible for a surgical procedure or at high risk of complications due to weight and related comorbidities. The program maximizes eligibility, reduces risk, improves outcomes and improves reimbursement and bottom line for surgeons, health care systems and payors.
Active Therapy Systems (Lexington, KY) improves the way people access and receive Physical Therapy treatments for conditions like Parkinson’s Disease, Multiple Sclerosis, and a variety of memory and cognitive problems. The solution provides in-home daily treatment options and better connects patients to their doctors and physical therapists, helping them to stay healthier and independent longer.
Heartbeat Technologies (Charleston, SC) is an interdisciplinary team of surgeons, medical students, engineers, and designers at the Medical University of South Carolina that has developed a novel CPR adjunct device, The Saver. Currently, one in every seven Americans dies from sudden cardiac arrest. Heartbeat aims to increase the survival rate for cardiac arrest patients and minimize neurological impairment.
iMama (Raleigh, NC) is a digital health platform using artificial intelligence to help mothers prolong their breastfeeding cycle and help employers to provide nursing moms with lactation support benefits. The solution enables everyday tracking of breastfeeding sessions and easy access to telehealth services for secure communication between the mother and the lactation consultant.
Melanated Healthcare (Louisville, KY) is a mobile application that increases access to quality care by helping black and persons of color (POC) locate melanated healthcare professionals in their area. Melanated Healthcare aims to decrease health disparities by increasing access to culturally competent, exceptional healthcare professionals.
ModoScript (Boston, MA) is a digital health company that provides remote monitoring of rigorous treatment protocols in oral oncology and other chronic conditions that require continuous treatment assessment. This SaaS and big data analytics solution improves access and quality of remote treatment delivery while reducing costs.
TremBlock (Plantation, FL) is a unique mouthguard targeted for use in patients with epilepsy or other known seizure disorders. The device is capable of dispensing a quick acting seizure aborting medication designed to protect teeth, tongue, lips and other oral structures from injury.
The XLerateHealth (XLH) mission is to cultivate and grow impactful healthcare innovation in the Midwest, Southeast and other areas of the country where great innovation often goes unrecognized and underfunded. Founded in 2012, XLH supports the development of healthcare innovation through its healthcare accelerator, which helps start-up founders commercialize their business and attract funding. XLerateHealth also leads the efforts to build and operate the XLerator Network, an NIH-funded partnership with Academic Lead University of Kentucky along with 24 other academic institutions in the Southeast. The objective of this work is to increase the commercialization of promising life science and healthcare innovations in the NIH-designated Southeast Institutional Development Award (IDeA) states.
Find out more about XLH by visiting www.xleratehealth.com. XLH is on Facebook, LinkedIn and Twitter @XlerateHealth.